Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

Ann: Second Supplementary Scheme Booklet, page-21

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 21 Last

Share
Profile

Follow
showie

644 Posts.

81

25/08/22

14:52

Post #: 63321763
Share

Originally posted by Maltsy: ↑

Page 3, Section 1:

the Bridging Loan (defined below) entered into between ResApp and Pfizer Australia to
provide for ResApp’s short-term working capital needs during the extended Scheme period;
.....
Importantly, ResApp Shareholders are advised that if the Scheme is not implemented by
23 September 2022, the current indicative Implementation Date, and the Scheme Implementation
Deed is terminated, ResApp will be required to immediately secure external funding to repay the
Bridging Loan (defined below) and to continue to fund ordinary further business activities.

The Board believes it will be able to raise the required funds on the equity capital market, albeit
potentially at a significant discount to the prevailing share price, and in this regard notes that it has
its full placement capacity under Listing Rule 7.1 available to facilitate a prompt placement of Shares
to one or more third parties. The Board is also investigating alternative financing arrangements,
including the borrowing of money against the future receipt of any tax rebates.

Expand

This says to me that revenue might be closer than we think. As it is not a solution to RAPs capital requirements at current cash burn vs. incoming revenue.

There's been a long silence since Pfizer began co-developing the covid screening app. Maybe we are on to something.

How has this screening APP not been sold to lifeworks, etc EAPs

RAP Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

There are more pages in this discussion • 235 more messages in this thread...

First 21 Last

Add RAP (ASX) to my watchlist

Ann: Second Supplementary Scheme Booklet, page-21

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Featured News